ETFs & Funds
All the reasons Marvell investors are ’freaking out’ as Lumentum deal rumors swirl
Investors are nervous that Marvell would have to pay a big premium , and wait a while for China to approve any deal.
Investors are nervous that Marvell would have to pay a big premium , and wait a while for China to approve any deal.
Further reading
More ETFs & Funds briefs · Thursday, October 29, 2026
ETFs & FundsCoca-Cola Sips on Profits While Inflation Sweats
US MarketsFlorida is voting on whether to slash property taxes. Here’s who it would benefit , and hurt.
US MarketsInflation surges, PCE shows. Fed pause on rate hikes unlikely to last with prices still rising.
ETFs & FundsInvestors Look Beyond AI
ETFs & FundsTesla Tailwinds Could Propel This New ETF
ETFs & FundsThe Fed held off on a rate hike. Today’s GDP and inflation reports could make waiting harder.
ETFs & FundsMedicare used AI to pre-approve patient care, and it immediately led to a large drop in medical services
ETFs & FundsCommodity ETFs: Beyond the Gold Trade
ETFs & FundsServiceNow stock is on track for its largest drop on record. But JPMorgan sees a bright spot.
ETFs & FundsHedge funds reduce Bitcoin ETF exposure as sovereign and wealth investors increase allocations
US MarketsNBA star LaMelo Ball is selling his $2.6 million luxury condo in Charlotte after leaving the Hornets
US MarketsChipotle expects modestly higher sales this year as drive-thru ‘Chipotlanes’ come to more stores
US MarketsU.S. oil-refinery stocks are up roughly 150% this year. How long could this historic run last?
US MarketsThe U.S. government will no longer penalize American companies for making six popular peptides
ETFs & Funds1 Year of DRNZ: A Closer Look at Defense ETFs
ETFs & FundsThe Euro vs the Swiss Franc
ETFs & FundsWith High Treasury Yields, the Details Matter
ETFs & FundsThis ETF Embraced Change & Thrived